Loading…
Breast Cancer Patient Equity Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
1d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Breast Cancer Patient Equity Act This bill provides for Medicare coverage of custom fabricated breast prostheses following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses. Currently, Medicare covers surgically implanted breast prostheses, as well as some external breast prostheses (e.g., post-surgical bras).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2020 · fourth_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act H.R.8845/S.5051 - The Multi Cancer Early Detection Screening Coverage Act H.R. 913/S.4742 Clinical Treatment Act Medicare coverage policies for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Proposed waivers under Sections 1115 and 1332 of the Social Security Act Proposed rule related to Securing Updated and Necessary Statutory Evaluations Timely Proposed rule on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency Proposed rules on Notice of Benefit and Payment Parameters Interim Final Rule on Most Favored Nation Policy Coverage for telemedicine in Medicare Radiation Oncology Alternative Payment Model 2021 Medicare Physician Fee Schedule Proposed Rule 2021 Medicare Hospital Outpatient Prospective Payment System Proposed Rule
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2020 · third_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act Medicare coverage policies for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Coverage for telemedicine in Medicare FY21 Inpatient Prospective Payment System Proposed Rule 2021 Medicare Physician Fee Schedule Proposed Rule 2021 Medicare Hospital Outpatient Prospective Payment System Proposed Rule
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
2020 · second_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act Medicare coverage policies for drugs and drug pricing Issues related to continued Medicaid coverage for high-quality, affordable health care Medicaid, Medicare and other policy changes due to the COVID-19 emergency Coverage for telemedicine in Medicare
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2020 · first_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act Medicare coverage policies for drugs and drug pricing Issues related to continued Medicaid coverage for high-quality, affordable health care Medicaid, Medicare and other policy changes due to the COVID-19 emergency
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act H.R.3502 - Protecting People From Surprise Medical Bills Act Medicare coverage policies for drugs Issues related to continued Medicaid coverage for high-quality, affordable health care
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · third_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/S/3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245); Health and science related funding issues; H.J. Res. 31 Consolidated Appropriations Act of 2019; fiscal year 2020 Appropriations; H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act H.R.3502 - Protecting People From Surprise Medical Bills Act Medicare coverage policies for drugs Issues related to continued Medicaid coverage for high-quality, affordable health care
Client expense: $90,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · second_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act Medicare coverage policies for drugs Issues related to continued Medicaid coverage for high-quality, affordable health care
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/S/3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245); Health and science related funding issues; H.J. Res. 31 Consolidated Appropriations Act of 2019; fiscal year 2020 Appropriations; H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
Client expense: $80,000 · Firm income: Not reported
2019 · first_quarter · Insurance
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1730/S.741 - Cancer Drug Parity Act Coverage of diagnostic imaging for breast cancer patients and survivors
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/S/3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245); Health and science related funding issues; H.J. Res. 31 Consolidated Appropriations Act of 2019; fiscal year 2020 Appropriations.
Client expense: $80,000 · Firm income: Not reported
| Democratic |
| MI |
| Ann M. Kuster | Democratic | NH |
| Bobby L. Rush | Democratic | IL |
| Charlie Crist | Democratic | FL |
| Cheri Bustos | Democratic | IL |
| Cynthia Axne | Democratic | IA |
| Daniel T. Kildee | Democratic | MI |
| David Loebsack | Democratic | IA |
| Debbie Mucarsel-Powell | Democratic | FL |
| Debbie Wasserman Schultz | Democratic | FL |
| Ed Case | Democratic | HI |
| Eleanor Holmes Norton | Democratic | DC |
| Fred Upton | Republican | MI |
| Glenn Thompson | Republican | PA |
| Jackie Walorski | Republican | IN |
| James P. McGovern | Democratic | MA |
| Jimmy Panetta | Democratic | CA |
| John Lewis | Democratic | GA |
| Kendra S. Horn | Democratic | OK |
| Lee M. Zeldin | Republican | NY |
| Lisa Blunt Rochester | Democratic | DE |
| Lloyd Doggett | Democratic | TX |
| Mark Pocan | Democratic | WI |
| Martha Roby | Republican | AL |
| Mary Gay Scanlon | Democratic | PA |
| Matt Gaetz | Republican | FL |
| Mike Kelly | Republican | PA |
| Nanette Diaz Barragán | Democratic | CA |
| Ron Kind | Democratic | WI |
| Steve King | Republican | IA |
| Susan A. Davis | Democratic | CA |
| Susan W. Brooks | Republican | IN |
| Suzan K. DelBene | Democratic | WA |
| Terri A. Sewell | Democratic | AL |
| Thomas Massie | Republican | KY |
| Thomas R. Suozzi | Democratic | NY |
| Tony Cárdenas | Democratic | CA |
| Tulsi Gabbard | Democratic | HI |
| Yvette D. Clarke | Democratic | NY |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE